Zanolimumab

Zanolimumab is an investigational human monoclonal antibody and an immunosuppressive drug. It was developed with the goal of treatment of rheumatoid arthritis, psoriasis, melanoma, cutaneous and peripheral T-cell lymphoma.Statement On A Nonproprietary Name Adopted By The USAN Council - Zanolimumab , American Medical Association. Development of the drug was ultimately discontinued with termination of all trials.

References